Q2 2024 · 13F-HR
GREAT POINT PARTNERS LLCholdings as filed
Filed 2024-08-14 · accession 0001172661-24-003577
$522.0M
Reported value
33
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| M96088105 | URGN | UROGEN PHARMA LTD | $48.8M | 9.34% | 2,906,259 | Common | SHARED |
| 64135M105 | NGNE | NEUROGENE INC | $36.5M | 7.00% | 1,004,291 | Common | SHARED |
| 00370M103 | ABVX | ABIVAX SA | $32.7M | 6.26% | 2,472,188 | Common | SHARED |
| N5749R100 | 2GH | MERUS N V | $31.0M | 5.93% | 523,288 | Common | SHARED |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $28.3M | 5.43% | 2,636,864 | Common | SHARED |
| 03940C100 | ACLXGBX | ARCELLX INC | $27.2M | 5.20% | 492,000 | Common | SHARED |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $26.7M | 5.11% | 2,374,000 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $26.6M | 5.10% | 2,451,772 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $25.7M | 4.92% | 474,202 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $19.6M | 3.76% | 757,929 | Common | SHARED |
| 457669307 | INSM | INSMED INC | $16.8M | 3.21% | 250,000 | Common | SHARED |
| G9TY5A101 | ZURA | ZURA BIO LTD | $16.2M | 3.11% | 4,642,241 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $15.8M | 3.02% | 1,338,568 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $15.7M | 3.01% | 330,000 | Common | SHARED |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $14.9M | 2.85% | 7,419,355 | Common | SHARED |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $14.8M | 2.84% | 1,495,500 | Common | SHARED |
| 68404V100 | — | OPTINOSE INC | $14.3M | 2.73% | 13,727,097 | Common | SHARED |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $12.9M | 2.46% | 5,791,594 | Common | SHARED |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $12.7M | 2.43% | 1,601,527 | Common | SHARED |
| 69012T305 | OTLK | OUTLOOK THERAPEUTICS INC | $12.6M | 2.41% | 1,701,510 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $12.0M | 2.29% | 3,441,667 | Common | SHARED |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $9.1M | 1.75% | 402,015 | Common | SHARED |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $8.6M | 1.65% | 796,880 | Common | SHARED |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $7.8M | 1.50% | 1,149,406 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $6.5M | 1.25% | 500,000 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $5.5M | 1.05% | 940,831 | Common | SHARED |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $5.3M | 1.02% | 1,529,338 | Common | SHARED |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.1M | 0.98% | 500,000 | Common | SHARED |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $4.8M | 0.93% | 1,486,544 | Common | SHARED |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $3.7M | 0.72% | 499,152 | Common | SHARED |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $3.2M | 0.61% | 134,612 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $626,500 | 0.12% | 25,000 | Common | SHARED |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $50,400 | 0.01% | 30,000 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.